Search Results - "Yarbrough, W.G."

Comparison of Upfront Surgery Versus Chemoradiation for cT1-2 N1-2b Oropharynx Squamous Cell Carcinoma Based on Human Papillomavirus Status by Kelly, J.R, Park, H.S.M, An, Y, Decker, R.H, Contessa, J.N, Yarbrough, W.G, Burtness, B.A, Judson, B.L, Husain, Z.A

Get full text

Sensitivity of HPV (+) Oropharyngeal Head and Neck Cancers to Poly (ADP-ribose) Polymerase inhibitor (PARPi), due to Defective Homologous Recombination Repair by Cha, Y.I, Isaeva, N, Yarbrough, W.G

Get full text

191 (PB179): Novel strategy to improve response of high risk HPV+ HNSCC to radiation therapy by Vemulamanda, S., Kothari, A., Schrank, T., Yarbrough, W.G., Issaeva, N.

Get full text

Local Regional Recurrence rates for pT1-2 N0 Oral Tongue Squamous Cell Carcinoma Treated with Surgery Alone at a High Volume Academic Multidisciplinary Head and Neck Oncology Program by Wilson, J.M., Chera, B.S., Tan, X., Shen, C., Lumley, C., Coniglio, A., Weissler, M., Yarbrough, W.G., Hackman, T., Blumberg, J., Zanation, A., Thorp, B., Patel, S.

Get full text

PPM1A is a RelA phosphatase with tumor suppressor-like activity by Lu, X, An, H, Jin, R, Zou, M, Guo, Y, Su, P-F, Liu, D, Shyr, Y, Yarbrough, W G

“…Nuclear factor-κB (NF-κB) signaling contributes to human disease processes, notably inflammatory diseases and cancer. NF-κB has a role in tumorigenesis and…”
Get full text

TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior by Ivanov, S V, Panaccione, A, Brown, B, Guo, Y, Moskaluk, C A, Wick, M J, Brown, J L, Ivanova, A V, Issaeva, N, El-Naggar, A K, Yarbrough, W G

“…Treatment options for adenoid cystic carcinoma (ACC) of the salivary gland, a slowly growing tumor with propensity for neuroinvasion and late recurrence, are…”
Get full text

Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting by Sandulache, V.C., Lei, Y.L., Heasley, L.E., Chang, M., Amos, C.I., Sturgis, E.M., Graboyes, E., Chiao, E.Y., Rogus-Pulia, N., Lewis, J., Madabhushi, A., Frederick, M.J., Sabichi, A., Ittmann, M., Yarbrough, W.G., Chung, C.H., Ferrarotto, R., Mai, Weiyuan, Skinner, H.D., Duvvuri, U., Gerngross, P., Sikora, A.G.

Get full text

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma by Chung, C.H., Aulino, J., Muldowney, N.J., Hatakeyama, H., Baumann, J., Burkey, B., Netterville, J., Sinard, R., Yarbrough, W.G., Cmelak, A.J., Slebos, R.J., Shyr, Y., Parker, J., Gilbert, J., Murphy, B.A.

“…Our previous study has shown that nuclear factor-kappa B (NF-κB)-signaling pathway was associated with a higher rate of recurrence in head and neck squamous…”
Get full text

Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon by Clark, E S, Brown, B, Whigham, A S, Kochaishvili, A, Yarbrough, W G, Weaver, A M

“…11q13 amplification is a late-stage event in several cancers that is often associated with poor prognosis. Among 11q13-amplified genes, the actin assembly…”
Get full text